RecruitingNCT02994719

Gait Analysis in Neurological Disease

Gait Pattern Analysis in Neurological Disease


Sponsor

Beth Israel Deaconess Medical Center

Enrollment

120 participants

Start Date

Mar 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to investigate whether speed-dependent measures of gait can be identified in patients with neurological conditions that affect gait, particularly in subjects with parkinsonian disorders.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is using advanced motion-capture technology to analyze how people with Parkinson's disease walk, to better understand how the disease affects movement and to track changes over time. **You may be eligible if...** - You are between 18 and 85 years old - You have been diagnosed with Parkinson's disease, showing at least 2 of the main signs: slowness of movement, resting tremor, muscle stiffness, or balance problems - Healthy volunteers of the same age range are also eligible for comparison - If you have cognitive difficulties, you may still participate with the support of a legal representative **You may NOT be eligible if...** - You are outside the age range of 18 to 85 - You do not have at least 2 of the key Parkinson's symptoms (for the affected group) - You have severe cognitive impairment without a legal representative available Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAnti-Parkinson medication

During the optional second visit subjects with neurological disease and already on anti-parkinson medication are asked to come off their anti-parkinson medication.

DEVICEDeep Brain Stimulation

During the optional second visit subjects with neurological disease already treated with deep brain stimulation are asked to come temporarily stop deep brain stimulation and resume stimulation, with walking trials done in each condition.


Locations(1)

Clinical Research Center BIDMC

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02994719


Related Trials